Konstantinos Syrigos to Receptors, Urokinase Plasminogen Activator
This is a "connection" page, showing publications Konstantinos Syrigos has written about Receptors, Urokinase Plasminogen Activator.
Connection Strength
0.045
-
An open label trial of anakinra to prevent respiratory failure in COVID-19. Elife. 2021 03 08; 10.
Score: 0.045
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.